Dan Granberg

Publications
Public outreach and news

Articles

Article: JOURNAL OF NEUROENDOCRINOLOGY. 2023;35(10):e13342
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours
Edfeldt K; Hellman P; Granberg D; Lagergren P; Thiis-Evensen E; Sundin A; Andersson C
Article: FRONTIERS IN PEDIATRICS. 2022;10:836230
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of ¹⁷⁷Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N
Sundquist F; Georgantzi K; Jarvis KB; Brok J; Koskenvuo M; Rascon J; van Noesel M; Grybaeck P; Nilsson J; Braat A; Sundin M; Wessman S; Herold N; Hjorth L; Kogner P; Granberg D; Gaze M; Stenman J
Article: NEUROENDOCRINOLOGY. 2021;111(4):330-343
¹⁷⁷Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants
Fross-Baron K; Garske-Roman U; Welin S; Granberg D; Eriksson B; Khan T; Sandstrom M; Sundin A
Article: CANCERS. 2019;11(7):E909-909
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE
Vyakaranam AR; Crona J; Norlen O; Granberg D; Garske-Roman U; Sandstrom M; Fross-Baron K; Thiis-Evensen E; Hellman P; Sundin A
Article: ENDOCRINE-RELATED CANCER. 2019;26(2):227-239
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Carlsen EA; Fazio N; Granberg D; Grozinsky-Glasberg S; Ahmadzadehfar H; Grana CM; Zandee WT; Cwikla J; Walter MA; Oturai PS; Rinke A; Weaver A; Frilling A; Gritti S; Arveschoug AK; Meirovitz A; Knigge U; Sorbye H
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2018;45(6):970-988
Prospective observational study of ¹⁷⁷Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
Garske-Roman U; Sandstrom M; Baron KF; Lundin L; Hellman P; Welin S; Johansson S; Khan T; Lundqvist H; Eriksson B; Sundin A; Granberg D
Article: ACTA ONCOLOGICA. 2018;57(4):516-521
Kidney dosimetry during ¹⁷⁷Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance
Sandstrom M; Garske-Roman U; Johansson S; Granberg D; Sundin A; Freedman N
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2017;41(9):1238-1246
Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region
Casar-Borota O; Botling J; Granberg D; Stigare J; Wikstrom J; Boldt HB; Kristensen BW; Ponten F; Trouillas J
Article: JOURNAL OF GLOBAL ONCOLOGY. 2017;3(1):43-53
Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.
Singh S; Granberg D; Wolin E; Warner R; Sissons M; Kolarova T; Goldstein G; Pavel M; Öberg K; Leyden J
Article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2017;122(1):43-50
Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors
Carlbom L; Caballero-Corbalan J; Granberg D; Sorensen J; Eriksson B; Ahlstrom H
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(8):1425-1431
Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases
Barbier CE; Garske-Roman U; Sandstrom M; Nyman R; Granberg D
Article: NEUROENDOCRINOLOGY. 2016;103(3-4):345-353
Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
Antonodimitrakis PC; Sundin A; Wassberg C; Granberg D; Skogseid B; Eriksson B
Article: JOURNAL OF NUCLEAR MEDICINE. 2015;56(2):177-182
Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE
Ilan E; Sandstrom M; Wassberg C; Sundin A; Garske-Roman U; Eriksson B; Granberg D; Lubberink M
Article: FAMILIAL CANCER. 2014;13(1):121-125
MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours
Crona J; Maharjan R; Verdugo AD; Stalberg P; Granberg D; Hellman P; Bjorklund P
Article: JOURNAL OF NUCLEAR MEDICINE. 2014;55(2):204-210
Quantitative and Qualitative Intrapatient Comparison of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
Velikyan I; Sundin A; Sorensen J; Lubberink M; Sandstrom M; Garske-Roman U; Lundqvist H; Granberg D; Eriksson B
Article: PLOS ONE. 2014;9(1):e86756
Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours
Crona J; Nordling M; Maharjan R; Granberg D; Stalberg P; Hellman P; Bjorklund P
Article: JOURNAL OF NUCLEAR MEDICINE. 2013;54(10):1755-1759
Comparative Biodistribution and Radiation Dosimetry of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE in Patients with Neuroendocrine Tumors
Sandstrom M; Velikyan I; Garske-Roman U; Sorensen J; Eriksson B; Granberg D; Lundqvist H; Sundin A; Lubberink M
Article: WORLD JOURNAL OF SURGERY. 2013;37(7):1701-1706
Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall?
Crona J; Granberg D; Norlen O; Warnberg F; Stalberg P; Hellman P; Bjorklund P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2013;98(7):E1266-E1271
Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing
Crona J; Verdugo AD; Maharjan R; Stalberg P; Granberg D; Hellman P; Bjorklund P
Article: ENDOCRINE CONNECTIONS. 2013;2(2):104-111
Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma
Crona J; Verdugo AD; Granberg D; Welin S; Stalberg P; Hellman P; Bjorklund P
Article: CHEST. 2013;143(4):955-962
Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Advanced Lung Neuroendocrine Tumors Analysis of the Phase 3, Randomized, Placebo-Controlled RADIANT-2 Study
Fazio N; Granberg D; Grossman A; Saletan S; Klimovsky J; Panneerselvam A; Wolin EM
Article: LUNG CANCER. 2013;79(3):289-293
Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre
Crona J; Bjorklund P; Welin S; Kozlovacki G; Oberg K; Granberg D
Article: NEUROENDOCRINOLOGY. 2013;98(2):151-155
Effect of Temozolomide in Patients with Metastatic Bronchial Carcinoids
Crona J; Fanola I; Lindholm DP; Antonodimitrakis P; Oberg K; Eriksson B; Granberg D
Article: JOURNAL OF NUCLEAR MEDICINE. 2013;54(1):33-41
Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing ¹⁷⁷Lu-DOTA-Octreotate Treatment
Sandstrom M; Garske-Roman U; Granberg D; Johansson S; Widstrom C; Eriksson B; Sundin A; Lundqvist H; Lubberink M
Article: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2012;12(7):783-790
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro
Larsson DE; Hassan SB; Oberg K; Granberg D
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2012;97(4):E627-E631
Unusual Complication of a Pancreatic Neuroendocrine Tumor Presenting with Malignant Hypercalcemia
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Oberg K
Article: MEDICAL ONCOLOGY. 2012;29(1):301-303
Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma
Lindholm DP; Eriksson B; Granberg D
Article: PATIENT PREFERENCE AND ADHERENCE. 2012;6:703-710
Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel(®) given by either self/partner or a health care professional.
Johanson V; Wilson B; Abrahamsson A; Jianu C; Calissendorff J; Wall N; Grønbæk H; Florholmen J; Ohberg A; Granberg D
Article: INTERNATIONAL JOURNAL OF HEPATOLOGY. 2012;2012:790635-2
Treatment of liver metastases in patients with neuroendocrine tumors.
Granberg D; de Herder W; O'Toole D; Kvols L
Article: ACTA ONCOLOGICA. 2012;51(1):86-96
Minor changes in effective half-life during fractionated ¹⁷⁷Lu-Octreotate therapy
Garske U; Sandstrom M; Johansson S; Sundin A; Granberg D; Eriksson B; Lundqvist H
Article: THERANOSTICS. 2012;2(5):459-471
Lessons on Tumour Response: Imaging during Therapy with ¹⁷⁷Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma
Garske U; Sandstrom M; Johansson S; Granberg D; Lundqvist H; Lubberink M; Sundin A; Eriksson B
Article: WORLD JOURNAL OF GASTROENTEROLOGY. 2011;17(25):3066-3068
Gastric carcinoid in a patient infected with Helicobacter pylori: A new entity?
Antonodimitrakis P; Tsolakis A; Welin S; Kozlovacki G; Oberg K; Granberg D
Article: CLINICAL COLORECTAL CANCER. 2011;10(2):108-112
Appendiceal Adenocarcinoids with Peritoneal Carcinomatosis Treated with Cytoreductive Surgery and Intraperitoneal Chemotherapy: A Retrospective Study of In Vitro Drug Sensitivity and Survival
Cashin P; Nygren P; Hellman P; Granberg D; Andreasson H; Mahteme H
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2010;37(2):212-225
Individualized dosimetry in patients undergoing therapy with ¹⁷⁷Lu-DOTA-D-Phe¹-Tyr³-octreotate
Sandstrom M; Garske U; Granberg D; Sundin A; Lundqvist H
Article: ANTICANCER RESEARCH. 2010;30(1):149-156
The Cytotoxic Agents NSC-95397, Brefeldin A, Bortezomib and Sanguinarine Induce Apoptosis in Neuroendocrine Tumors In Vitro
Larsson DE; Wickstrom M; Hassan S; Oberg K; Granberg D
Article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2009;65(1):5-12
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines
Larsson DE; Hassan S; Larsson R; Oberg K; Granberg D
Article: NEUROENDOCRINOLOGY. 2009;89(3):302-307
Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors
Welin S; Stridsberg M; Cunningham J; Granberg D; Skogseid B; Oberg K; Eriksson B; Janson ET
Article: WORLD JOURNAL OF SURGERY. 2008;32(5):930-938
Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors
Eriksson J; Stalberg P; Nilsson A; Krause J; Lundberg C; Skogseid B; Granberg D; Eriksson B; Akerstom G; Hellman P
Article: DIGESTION. 2008;77(2):92-95
Regression of a large malignant gastrinoma on treatment with Sandostatin LAR®:: A case report
Granberg D; Jacobsson H; Oberg K; Gustavsson J; Lehtihet M
Article: MEDICAL ONCOLOGY. 2007;24(3):330-337
Endocrine pancreatic tumors with glucagon hypersecretion:: a retrospective study of 23 cases during 20 years
Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
Article: CLINICAL CANCER RESEARCH. 2007;13(10):2986-2991
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
Ekeblad S; Sundin A; Janson ET; Welin S; Granberg D; Kindmark H; Dunder K; Kozlovacki G; Orlefors H; Sigurd M; Oberg K; Eriksson B; Skogseid B
Article: ACTA RADIOLOGICA. 2007;48(2):180-185
Liver embolization with trisacryl gelatin microspheres (Embosphere) in patients with neuroendocrine tumors
Granberg D; Eriksson L-G; Welin S; Kindmark H; Janson ET; Skogseid B; Oberg K; Eriksson B; Nyman R
Article: ANTICANCER RESEARCH. 2006;26(6B):4125-4129
Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines
Larsson DE; Lovborg H; Rickardson L; Larsson R; Oberg K; Granberg D
Article: TUMOR BIOLOGY. 2006;27(3):153-157
Expression of tyrosine kinase receptors in lung carcinoids
Granberg D; Wilander E; Oberg K
Article: ACTA ONCOLOGICA. 2006;45(1):23-27
Gastrin-releasing-peptide in neuroendorine tumours
Granberg D; Skogseid B; Welin S; Örlefors H; Öberg K; Wilander E
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2004;151(1):107-112
High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours
Welin SV; Janson ET; Sundin A; Stridsberg M; Lavenius E; Granberg D; Skogseid B; Öberg KE; Eriksson BK
Article: CLINICAL ENDOCRINOLOGY. 2003;59(6):793-799
Octreoscan in patients with bronchial carcinoid tumours
Granberg D; Sundin A; Janson ET; Öberg K; Skogseid B; Westlin JE
Article: ANTICANCER RESEARCH. 2003;23(3B):2227-2232
In situ RNA-RNA hybridisation of phospholipase C β3 shows lack of expression in neuroendocrine tumours
Stålberg P; Granberg D; Carling T; Wilander E; Eriksson B; Gobl A; Akerström G; Rastad J; Modlin IM; Öberg K; Skogseid B
Article: ANNALS OF ONCOLOGY. 2001;12(10):1383-1391
Experience in treatment of metastatic pulmonary carcinoid tumors
Granberg D; Eriksson B; Wilander E; Grimfjärd P; Fjällskog ML; Öberg K; Skogseid B
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2000;85(9):3425-3430
Prognostic markers in patients with typical bronchial carcinoid tumors
Granberg D; Wilander E; Öberg K; Skogseid B
Article: INTERNATIONAL JOURNAL OF CANCER. 1999;84(5):484-488
Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors
Granberg D; Wilander E; Öberg K; Skogseid B
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1999;84(8):2712-2717
Plasma chromogranin A in patients with multiple endocrine neoplasia type 1
Granberg D; Stridsberg M; Seensalu R; Eriksson B; Lundqvist G; Öberg K; Skogseid B
Article: GUT. 1998;43(2):223-228
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids
Granberg D; Wilander E; Stridsberg M; Granerus G; Skogseid B; Öberg K
Article: INTERNATIONAL JOURNAL OF PUBLIC OPINION RESEARCH. 1995;7(3):199-210
INTENSE MINORITIES AND THE PATTERN OF PUBLIC-OPINION
GILLJAM M; GRANBERG D
Show more

All other publications

Review: CANCERS. 2023;15(22):5440
Lung Carcinoids: A Comprehensive Review for Clinicians
Granberg D; Juhlin CC; Falhammar H; Hedayati E
Review: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2021;106(5):e1937-e1952
Metastatic Pheochromocytomas and Abdominal Paragangliomas
Granberg D; Juhlin CC; Falhammar H
Review: FRONTIERS OF HORMONE RESEARCH. 2015;44:24-39
Biochemical Testing in Patients with Neuroendocrine Tumors
Granberg D
Letter: ACTA ONCOLOGICA. 2010;49(1):100-101
Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)
Kindmark H; Janson ET; Gustavsson B; Eriksson C; Larsson G; Granberg D; Kozlowacki G; Skogseid B; Welin S; Oberg K; Eriksson B
Review: EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2009;18(5):601-608
Investigational drugs for neuroendocrine tumours
Granberg D
Letter: ACTA ONCOLOGICA. 2008;47(6):1169-1171
Selective internal radiation therapy in patients with carcinoid liver metastases
Granberg D; Garske U; Welin S; Kindmark H; Oeberg K; Eriksson B; Nyman R
Review: CANCER CHEMOTHERAPY AND BIOLOGICAL RESPONSE MODIFIERS. 2005;22:471-483
Neuroendocrine tumours.
Granberg D; Oberg K
Published conference paper: WORLD JOURNAL OF SURGERY. 1996;20(7):872-877
Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I
Skogseid B; Oberg K; Eriksson B; Juhlin C; Granberg D; Akerstrom G; Rastad J

Articles

All other publications

News from KI

Events from KI